Document:

Exhibit 4.2

                          REGISTRATION RIGHTS AGREEMENT

      This Registration  Rights Agreement (this "Agreement") is made and entered
into as of April __, 2004, by and among DynTek,  Inc. (the  "Company"),  and the
investors   signatory   hereto  (each  a  "Purchaser"  and   collectively,   the
"Purchasers").

      This  Agreement is made  pursuant to the  Securities  Purchase  Agreement,
dated as of the date hereof among the Company and the Purchasers  (the "Purchase
Agreement").

      The Company and the Purchasers hereby agree as follows:

      1.  Definitions.  Capitalized  terms used and not otherwise defined herein
that are defined in the Purchase  Agreement  shall have the meanings  given such
terms in the Purchase Agreement. As used in this Agreement,  the following terms
shall have the following meanings:

      "Effectiveness  Date" means,  with respect to the  Registration  Statement
required  to be  filed  hereunder,  the  earlier  of (a) the 60th  calendar  day
following the Closing Date (or the 90th calendar day if reviewed by the SEC) and
(b)  the  date  on  which  the  Commission  declares  the  effectiveness  of the
Registration Statement.

      "Effectiveness Period" shall have the meaning set forth in Section 2(a).

      "Filing Date" means, with respect to the Registration  Statement  required
to be filed hereunder, four (4) Business Days following the Closing Date.

      "Holder" or  "Holders"  means the holder or  holders,  as the case may be,
from time to time of Registrable Securities (including any permitted assignee).

      "Indemnified Party" shall have the meaning set forth in Section 5(c).

      "Indemnifying Party" shall have the meaning set forth in Section 5(c).

      "Losses" shall have the meaning set forth in Section 5(a).

      "Proceeding"  means an action,  claim,  suit,  investigation or proceeding
(including,  without limitation, an investigation or partial proceeding, such as
a deposition), whether commenced or threatened.

      "Prospectus" means the prospectus  included in the Registration  Statement
(including,  without  limitation,  a prospectus  that  includes any  information
previously omitted from a prospectus filed as part of an effective  registration
statement in reliance upon Rule 430A  promulgated  under the Securities Act), as
amended or supplemented by any prospectus supplement,  with respect to the terms
of the  offering of any  portion of the  Registrable  Securities  covered by the
Registration  Statement,  and  all  other  amendments  and  supplements  to  the
Prospectus,  including post-effective  amendments, and all material incorporated
by reference or deemed to be incorporated by reference in such Prospectus.
<PAGE>

      "Registrable Securities" means the Shares and the Warrant Shares, together
with any  shares  of  Common  Stock  issued or  issuable  upon any stock  split,
dividend or other  distribution,  recapitalization or similar event with respect
to the  foregoing or in  connection  with any  anti-dilution  provisions  in the
Warrant.

      "Registration  Statement" means the registration statements required to be
filed  hereunder,  including  (in each  case)  the  Prospectus,  amendments  and
supplements  to the  registration  statement or  Prospectus,  including pre- and
post-effective  amendments,  all exhibits thereto, and all material incorporated
by reference  or deemed to be  incorporated  by  reference  in the  registration
statement.

      "Rule 415" means Rule 415  promulgated by the  Commission  pursuant to the
Securities  Act, as such Rule may be amended  from time to time,  or any similar
Rule or regulation  hereafter adopted by the Commission having substantially the
same effect as such Rule.

      "Rule 424" means Rule 424  promulgated by the  Commission  pursuant to the
Securities  Act, as such Rule may be amended  from time to time,  or any similar
Rule or regulation  hereafter adopted by the Commission having substantially the
same effect as such Rule.

      "Securities Act" means the Securities Act of 1933, as amended.

      "Warrants"  shall mean the Common Stock  purchase  warrants  issued to the
Purchasers pursuant to the Purchase Agreement.

      2. Mandatory Registration.

            (a) On or prior to the Filing Date,  the Company  shall  prepare and
file with the Commission the Registration  Statement  covering the resale of all
of the Registrable  Securities for an offering to be made on a continuous  basis
pursuant to Rule 415. The Registration  Statement required hereunder shall be on
Form S-3 (except if the Company is not then  eligible to register for resale the
Registrable  Securities on Form S-3, in which case the Registration  shall be on
another  appropriate form in accordance  herewith).  The Registration  Statement
required  hereunder shall contain (except if otherwise  directed by the Holders)
the "Plan of  Distribution"  attached hereto as Annex A. The Company shall cause
the Registration  Statement to become effective and remain effective as provided
herein.  The Company shall use its commercially  reasonable efforts to cause the
Registration  Statement to be declared  effective  under the  Securities  Act as
promptly as  possible  after the filing  thereof and shall use its  commercially
reasonable  efforts to keep the Registration  Statement  continuously  effective
under the Securities Act until the date which is two (2) years after the Closing
Date or such  earlier  date  when  all  Registrable  Securities  covered  by the
Registration Statement (a) have been sold pursuant to the Registration Statement
or an exemption from the registration  requirements of the Securities Act or (b)
may be sold without volume restrictions pursuant to Rule 144(k) as determined by
the counsel to the Company  pursuant to a written opinion letter to such effect,
addressed  and  acceptable  to the  Company's  transfer  agent and the  affected
Holders (the "Effectiveness Period").

                                      -2-
<PAGE>

            (b) If a Registration Statement is not filed on or prior to the date
that is four (4)  Business  Days  from the  date of  closing  of the sale of the
Shares and Warrants (the "Closing  Date"),  then in addition to any other rights
the Holders may have hereunder or under applicable law, the Company shall pay to
each Holder an amount in cash until the date a  Registration  Statement is filed
and/or the Shares may be sold  pursuant to Rule 144, as  liquidated  damages and
not as a penalty,  equal to (i) one (1%) percent of the aggregate purchase price
paid by such Holder pursuant to the Purchase Agreement for the first thirty (30)
days or any  part  thereof,  and (ii) an  additional  two  (2%)  percent  of the
aggregate  purchase  paid by such  Holder  thereunder  for each  thirty (30) day
period  subsequent  thereto,  such  payment(s)  to be made within seven (7) days
after the initial date of each such failure to file.

            (c) If (1) a Registration  Statement is not declared effective on or
prior to sixty (60) days from the Closing  Date (or ninety (90) days if reviewed
by the SEC), or (2) a  Registration  Statement  has been declared  effective and
subsequent  thereto  is not  effective  (or does not  permit  the  resale of the
Registrable  Securities  thereby)  for a period  of more than  thirty  (30) days
consecutively  until  the  Shares  may be  sold  pursuant  to  Rule  144(k)  (an
"Effectiveness  Default"),  then in addition to any other rights the Holders may
have hereunder or under  applicable law, the Company shall pay to each Holder an
amount in cash until the date a  Registration  Statement  is declared  effective
and/or the Shares may be sold pursuant to Rule 144(k)  pursuant to  subprovision
(1) above, or if previously  declared effective then in the situation covered by
subprovision  (2)  above  until  the date  the  Registration  Statement  becomes
effective again or otherwise  permits the resale of the  Registrable  Securities
covered thereby,  as liquidated  damages and not as a penalty,  equal to (i) one
(1%) percent of the aggregate purchase price paid by such Holder pursuant to the
Purchase Agreement for the first thirty (30) days or any part thereof,  and (ii)
an  additional  two (2%) percent of the  aggregate  purchase  price paid by such
Holder  thereunder  for each thirty  (30) day period  subsequent  thereto,  such
payment(s)  to be made  within  seven  (7)  days  after  the  date of each  such
Effectiveness   Default   set  forth   above  in   subsections   (i)  and  (ii).
Notwithstanding  the foregoing,  the Company shall have thirty (30) days to cure
an  Effectiveness  Default  after the date of its  occurrence  and to  deliver a
written statement to the Holders of Registrable  Securities certifying that such
Effectiveness  Default  has been so cured;  and if such cure is timely  and such
statement is timely delivered, the Company shall not be subject to the penalties
for  such  Effectiveness  Default;  provided,  however,  that  for  such  "cure"
provision to be applicable,  such Effectiveness  Default must result solely from
the Company's  inability to have the Registration  Statement be declared because
in good faith it is in the process of preparing  and filing its Annual Report on
Form 10-K.

      3. Registration Procedures.  In connection with the Company's registration
obligations hereunder, the Company shall:

            (a) Not less  than  three  (3)  Trading  Days,  which  shall  not be
included in the  calculation  of time period for the  purposes of the  Company's
obligations under this Agreement or under the Purchase  Agreement,  prior to the
filing of the Registration  Statement or any related Prospectus or any amendment
or supplement  thereto,  the Company shall, (i) furnish to the Holders copies of
all such documents  proposed to be filed  (including  documents  incorporated or
deemed  incorporated by reference to the extent  requested by such Person) which
documents  will be  subject to the  review of such  Holders,  and (ii) cause its
officers and directors,  counsel and

                                      -3-
<PAGE>

independent  certified public  accountants to respond to such inquiries as shall
be  necessary,  in the  reasonable  opinion of  respective  counsel to conduct a
reasonable investigation within the meaning of the Securities Act.

            (b) Prepare and file with the Commission such amendments,  including
post-effective amendments, to the Registration Statement and the Prospectus used
in connection  therewith as may be necessary to keep the Registration  Statement
continuously  effective  as to the  applicable  Registrable  Securities  for the
Effectiveness  Period;  (ii)  cause the  related  Prospectus  to be  amended  or
supplemented by any required  Prospectus  supplement,  and as so supplemented or
amended  to be  filed  pursuant  to Rule  424;  (iii)  respond  as  promptly  as
reasonably possible to any comments received from the Commission with respect to
the  Registration  Statement  or any  amendment  thereto  and,  as  promptly  as
reasonably possible, upon request,  provide the Holders true and complete copies
of all  correspondence  from and to the Commission  relating to the Registration
Statement;  and (iv) comply in all material  respects with the provisions of the
Securities  Act and the  Exchange  Act with  respect to the  disposition  of all
Registrable   Securities  covered  by  the  Registration  Statement  during  the
applicable  period in accordance with the intended methods of disposition by the
Holders thereof set forth in the Registration Statement as so amended or in such
Prospectus as so supplemented.

            (c)  Notify  the  Holders of  Registrable  Securities  to be sold as
promptly as reasonably possible (and, in the case of (i)(A) below, not less than
two (2) Trading Days prior to such filing) and (if requested by any such Person)
confirm  such  notice  in  writing  promptly  following  the day  (i)(A)  when a
Prospectus  or any  Prospectus  supplement  or  post-effective  amendment to the
Registration Statement is proposed to be filed; (B) when the Commission notifies
the Company whether there will be a "review" of the  Registration  Statement and
whenever the Commission  comments in writing on the Registration  Statement (the
Company  shall upon request  provide true and  complete  copies  thereof and all
written responses  thereto to each of the Holders);  and (C) with respect to the
Registration Statement or any post-effective amendment, when the same has become
effective;  (ii) of any request by the  Commission or any other Federal or state
governmental  authority  during the period of  effectiveness of the Registration
Statement  for  amendments  or  supplements  to the  Registration  Statement  or
Prospectus  or  for  additional  information;  (iii)  of  the  issuance  by  the
Commission  or any other  federal or state  governmental  authority  of any stop
order suspending the effectiveness of the Registration Statement covering any or
all of the Registrable  Securities or the initiation of any Proceedings for that
purpose;  (iv) of the receipt by the Company of any notification with respect to
the suspension of the  qualification  or exemption from  qualification of any of
the Registrable  Securities for sale in any  jurisdiction,  or the initiation or
threatening of any Proceeding for such purpose; and (v) of the occurrence of any
event or passage of time that makes the  financial  statements  included  in the
Registration Statement ineligible for inclusion therein or any statement made in
the Registration  Statement or Prospectus or any document incorporated or deemed
to be incorporated  therein by reference  untrue in any material respect or that
requires  any  revisions  to the  Registration  Statement,  Prospectus  or other
documents so that, in the case of the Registration  Statement or the Prospectus,
as the case may be, it will not contain any untrue  statement of a material fact
or omit to state any material fact required to be stated therein or necessary to
make the statements therein, in light of the circumstances under which they were
made, not misleading.

                                      -4-
<PAGE>

            (d) Use its  commercially  reasonable  efforts to avoid the issuance
of,  or, if  issued,  obtain  the  withdrawal  of (i) any order  suspending  the
effectiveness  of the  Registration  Statement,  or (ii) any  suspension  of the
qualification  (or  exemption  from  qualification)  of any  of the  Registrable
Securities for sale in any jurisdiction, at the earliest practicable moment.

            (e) Furnish to each Holder,  without charge,  at least one conformed
copy  of the  Registration  Statement  and  each  amendment  thereto,  including
financial statements and schedules,  all documents  incorporated or deemed to be
incorporated  therein by reference to the extent  requested by such Person,  and
all exhibits to the extent requested by such Person  (including those previously
furnished  or  incorporated  by  reference)  promptly  after the  filing of such
documents with the Commission.

            (f) Promptly deliver to each Holder,  without charge, as many copies
of the Prospectus or  Prospectuses  (including each form of prospectus) and each
amendment  or  supplement  thereto as such  Persons  may  reasonably  request in
connection  with resales by the Holder of  Registrable  Securities.  The Company
hereby  consents to the use of such  Prospectus and each amendment or supplement
thereto by each of the selling  Holders in connection with the offering and sale
of the  Registrable  Securities  covered by such Prospectus and any amendment or
supplement  thereto,  except after the giving of any notice  pursuant to Section
3(c).

            (g) Prior to any resale of Registrable  Securities by a Holder,  use
its commercially reasonable efforts to register or qualify or cooperate with the
selling  Holders  in  connection  with the  registration  or  qualification  (or
exemption from the registration or qualification) of such Registrable Securities
for the  resale  by the  Holder  under the  securities  or Blue Sky laws of such
jurisdictions  within the United  States as any Holder  reasonably  requests  in
writing,  to keep such  registration or qualification  (or exemption  therefrom)
effective  during the  Effectiveness  Period and to do any and all other acts or
things reasonably  necessary to enable the disposition in such  jurisdictions of
the Registrable Securities covered by the Registration Statement; provided, that
the Company  shall not be required  to qualify  generally  to do business in any
jurisdiction  where it is not then so  qualified,  subject  the  Company  to any
material tax in any such jurisdiction  where it is not then so subject or file a
general consent to service of process in any such jurisdiction.

            (h) If  requested  by the  Holders,  cooperate  with the  Holders to
facilitate  the timely  preparation  and delivery of  certificates  representing
Registrable  Securities  to  be  delivered  to  a  transferee  pursuant  to  the
Registration  Statement,  which  certificates  shall  be  free,  to  the  extent
permitted by the Purchase Agreement,  of all restrictive  legends, and to enable
such Registrable  Securities to be in such  denominations and registered in such
names as any such Holders may request.

            (i)  Upon  the  occurrence  of any  event  contemplated  by  Section
3(c)(v), as promptly as reasonably possible,  prepare a supplement or amendment,
including  a  post-effective  amendment,  to  the  Registration  Statement  or a
supplement to the related  Prospectus or any document  incorporated or deemed to
be incorporated  therein by reference,  and file any other required  document so
that,  as  thereafter  delivered,  neither the  Registration  Statement nor such
Prospectus will contain an untrue  statement of a material fact or omit to state
a  material  fact

                                      -5-
<PAGE>

required to be stated  therein or necessary to make the statements  therein,  in
light of the circumstances under which they were made, not misleading.

            (j)  Comply  with  all  applicable  rules  and  regulations  of  the
Commission.

            (k) The Company may require  each  selling  Holder to furnish to the
Company a  certified  statement  as to the  number  of  shares  of Common  Stock
beneficially owned by such Holder and, if required by the Commission, the person
thereof that has voting and  dispositive  control  over the shares.  Each Holder
agrees to  reasonably  cooperate  with the  Company  in the  preparation  of the
Registration  Statement  and  response  by the  Company to any  comments  by the
Commission.

      4.  Registration   Expenses.   All  fees  and  expenses  incident  to  the
performance  of or compliance  with this Agreement by the Company shall be borne
by the Company  whether or not any  Registrable  Securities are sold pursuant to
the Registration  Statement.  The fees and expenses referred to in the foregoing
sentence shall include, without limitation, (i) all registration and filing fees
(including,  without  limitation,  fees and expenses (A) with respect to filings
required  to be made with the Trading  Market on which the Common  Stock is then
listed for trading,  and (B) in compliance with applicable  state  securities or
Blue Sky laws), (ii) printing expenses (including, without limitation,  expenses
of printing certificates for Registrable Securities and of printing prospectuses
if the  printing of  prospectuses  is  reasonably  requested by the holders of a
majority of the Registrable Securities included in the Registration  Statement),
(iii) messenger, telephone and delivery expenses, (iv) fees and disbursements of
counsel for the Company, (v) Securities Act liability insurance,  if the Company
so desires  such  insurance,  and (vi) fees and  expenses  of all other  Persons
retained by the Company in connection with the  consummation of the transactions
contemplated  by this Agreement.  In addition,  the Company shall be responsible
for all of its internal expenses incurred in connection with the consummation of
the transactions contemplated by this Agreement (including,  without limitation,
all salaries and expenses of its  officers  and  employees  performing  legal or
accounting  duties),  the expense of any annual  audit and the fees and expenses
incurred in  connection  with the listing of the  Registrable  Securities on any
securities exchange as required hereunder.

      5. Indemnification

            (a)   Indemnification   by   the   Company.   The   Company   shall,
notwithstanding  any termination of this Agreement,  indemnify and hold harmless
each Holder, the officers, directors, agents and employees of each of them, each
Person who  controls  any such  Holder  (within the meaning of Section 15 of the
Securities  Act or Section 20 of the Exchange Act) and the officers,  directors,
agents and  employees of each such  controlling  Person,  to the fullest  extent
permitted  by  applicable  law,  from and against  any and all  losses,  claims,
damages,   liabilities,   costs  (including,   without  limitation,   reasonable
attorneys' fees) and expenses (including the cost (including without limitation,
reasonable  attorneys'  fees) and expenses  relating to an  Indemnified  Party's
actions to enforce the provisions of this Section 5)  (collectively,  "Losses"),
as incurred,  to the extent  arising out of or relating to any untrue or alleged
untrue statement of a material fact contained in the Registration Statement, any
Prospectus or any form of  prospectus or in any amendment or supplement  thereto
or in any preliminary prospectus,  or arising out of or relating

                                      -6-
<PAGE>

to any  omission or alleged  omission of a material  fact  required to be stated
therein  or  necessary  to make  the  statements  therein  (in  the  case of any
Prospectus  or form  of  prospectus  or  supplement  thereto,  in  light  of the
circumstances under which they were made) not misleading,  except to the extent,
but only to the extent,  that (1) such untrue  statements or omissions are based
solely  upon  information  regarding  such  Holder  furnished  in writing to the
Company by or on behalf of such  Holder  expressly  for use  therein,  or to the
extent that such  information  relates to such Holder or such Holder's  proposed
method of distribution of Registrable  Securities and was reviewed and expressly
approved  in  writing  by such  Holder  expressly  for  use in the  Registration
Statement,  such  Prospectus  or such form of  Prospectus or in any amendment or
supplement  thereto (it being  understood  that the Holder has approved  Annex A
hereto for this  purpose) or (2) in the case of an occurrence of an event of the
type specified in Section 3(c)(ii)-(v), the use by such Holder of an outdated or
defective  Prospectus after the Company has notified such Holder in writing that
the  Prospectus is outdated or defective and prior to the receipt by such Holder
of the Advice contemplated in Section 6(d). The Company shall notify the Holders
promptly of the institution,  threat or assertion of any Proceeding of which the
Company  is  aware in  connection  with the  transactions  contemplated  by this
Agreement.

            (b) Indemnification by Holders. Each Holder shall, severally and not
jointly,  indemnify  and hold  harmless the Company,  its  directors,  officers,
agents and employees,  each Person who controls the Company  (within the meaning
of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the
directors,  officers,  agents or employees of such controlling  Persons,  to the
fullest  extent  permitted by applicable  law,  from and against all Losses,  as
incurred,  to the extent arising out of or based upon: (x) such Holder's failure
to comply with the prospectus delivery requirements of the Securities Act or (y)
any untrue or alleged  untrue  statement  of a material  fact  contained  in any
Registration  Statement,  any Prospectus,  or any form of prospectus,  or in any
amendment or supplement thereto or in any preliminary prospectus, or arising out
of or relating to any omission or alleged  omission of a material  fact required
to be stated therein or necessary to make the statements  therein not misleading
(i) to the  extent,  but only to the  extent,  that  such  untrue  statement  or
omission is contained in any information so furnished in writing by or on behalf
of such Holder to the Company  specifically  for  inclusion in the  Registration
Statement  or such  Prospectus  or (ii)  to the  extent  that  (1)  such  untrue
statements or omissions are based solely upon information  regarding such Holder
furnished in writing to the Company by or on behalf of such Holder expressly for
use therein,  or to the extent that such  information  relates to such Holder or
such Holder's proposed method of distribution of Registrable  Securities and was
reviewed and expressly  approved in writing by such Holder  expressly for use in
the  Registration  Statement (it being  understood  that the Holder has approved
Annex A hereto for this purpose),  such Prospectus or such form of Prospectus or
in any amendment or supplement  thereto,  or (2) in the case of an occurrence of
an event of the type specified in Section  3(c)(ii)-(v),  the use by such Holder
of an outdated or  defective  Prospectus  after the  Company has  notified  such
Holder in writing that the  Prospectus is outdated or defective and prior to the
receipt by such Holder of the Advice  contemplated  in Section 6(d). In no event
shall the  liability of any selling  Holder  hereunder be greater in amount than
the dollar amount of the gross proceeds received by such Holder upon the sale of
the Registrable Securities giving rise to such indemnification obligation.

                                      -7-
<PAGE>

            (c) Conduct of Indemnification  Proceedings. If any Proceeding shall
be brought or asserted  against any Person  entitled to indemnity  hereunder (an
"Indemnified  Party"),  such Indemnified  Party shall promptly notify the Person
from whom  indemnity is sought (the  "Indemnifying  Party") in writing,  and the
Indemnifying Party shall have the right to assume the defense thereof, including
the employment of counsel  reasonably  satisfactory to the Indemnified Party and
the  payment  of all fees and  expenses  incurred  in  connection  with  defense
thereof; provided, that the failure of any Indemnified Party to give such notice
shall not relieve  the  Indemnifying  Party of its  obligations  or  liabilities
pursuant  to this  Agreement,  except  (and only) to the extent that it shall be
finally determined by a court of competent  jurisdiction (which determination is
not subject to appeal or further review) that such failure shall have materially
prejudiced the Indemnifying Party.

      An Indemnified  Party shall have the right to employ  separate  counsel in
any such Proceeding and to participate in the defense thereof,  but the fees and
expenses of such counsel  shall be at the expense of such  Indemnified  Party or
Parties  unless:  (1) the  Indemnifying  Party has agreed in writing to pay such
fees and  expenses;  (2) the  Indemnifying  Party shall have failed  promptly to
assume  the  defense  of  such  Proceeding  and  to  employ  counsel  reasonably
satisfactory to such Indemnified Party in any such Proceeding;  or (3) the named
parties to any such Proceeding  (including any impleaded  parties)  include both
such Indemnified  Party and the Indemnifying  Party, and such Indemnified  Party
shall have been  advised by counsel  that a conflict  of  interest  is likely to
exist if the same  counsel  were to  represent  such  Indemnified  Party and the
Indemnifying  Party (in which  case,  if such  Indemnified  Party  notifies  the
Indemnifying  Party in writing that it elects to employ separate  counsel at the
expense of the Indemnifying  Party,  the  Indemnifying  Party shall not have the
right to assume the defense  thereof and the reasonable fees and expenses of one
separate counsel for all Indemnified Parties in any matters related on a factual
basis shall be at the expense of the Indemnifying Party). The Indemnifying Party
shall not be liable for any settlement of any such Proceeding  affected  without
its written  consent,  which  consent  shall not be  unreasonably  withheld.  No
Indemnifying  Party shall,  without the prior written consent of the Indemnified
Party,  effect any settlement of any pending  Proceeding in respect of which any
Indemnified Party is a party,  unless such settlement  includes an unconditional
release of such  Indemnified  Party from all  liability  on claims  that are the
subject matter of such Proceeding.

      All  reasonable  fees and  expenses of the  Indemnified  Party  (including
reasonable  fees  and  expenses  to  the  extent  incurred  in  connection  with
investigating   or  preparing  to  defend  such   Proceeding  in  a  manner  not
inconsistent  with this  Section)  shall be paid to the  Indemnified  Party,  as
incurred,  within  ten  (10)  Trading  Days of  written  notice  thereof  to the
Indemnifying  Party;  provided,   that  the  Indemnified  Party  shall  promptly
reimburse  the  Indemnifying  Party for that  portion of such fees and  expenses
applicable to such actions for which such  Indemnified  Party is not entitled to
indemnification  hereunder,  determined  based upon the  relative  faults of the
parties.

            (d) Contribution.  If a claim for indemnification under Section 5(a)
or 5(b) is unavailable  to an  Indemnified  Party (by reason of public policy or
otherwise),   then  each  Indemnifying  Party,  in  lieu  of  indemnifying  such
Indemnified  Party,  shall  contribute  to the  amount  paid or  payable by such
Indemnified  Party  as a  result  of  such  Losses,  in  such  proportion

                                      -8-
<PAGE>

as is appropriate to reflect the relative  fault of the  Indemnifying  Party and
Indemnified  Party in connection with the actions,  statements or omissions that
resulted in such Losses as well as any other relevant equitable  considerations.
The relative fault of such  Indemnifying  Party and  Indemnified  Party shall be
determined by reference to, among other things,  whether any action in question,
including any untrue or alleged untrue  statement of a material fact or omission
or alleged omission of a material fact, has been taken or made by, or relates to
information  supplied by, such Indemnifying  Party or Indemnified Party, and the
parties'  relative intent,  knowledge,  access to information and opportunity to
correct or prevent  such  action,  statement  or  omission.  The amount  paid or
payable by a party as a result of any Losses shall be deemed to include, subject
to the limitations set forth in Section 5(c), any reasonable attorneys' or other
reasonable  fees or  expenses  incurred  by such  party in  connection  with any
Proceeding to the extent such party would have been indemnified for such fees or
expenses if the  indemnification  provided for in this Section was  available to
such party in accordance with its terms.

            (e) The parties hereto agree that it would not be just and equitable
if  contribution  pursuant  to this  Section  5(d) were  determined  by pro rata
allocation or by any other method of allocation  that does not take into account
the equitable considerations referred to in the immediately preceding paragraph.
Notwithstanding the provisions of this Section 5(d), no Holder shall be required
to contribute, in the aggregate, any amount in excess of the amount by which the
proceeds  actually  received  by such  Holder  from the sale of the  Registrable
Securities subject to the Proceeding exceeds the amount of any damages that such
Holder has  otherwise  been  required to pay by reason of such untrue or alleged
untrue statement or omission or alleged omission, except in the case of fraud by
such Holder. The indemnity and contribution agreements contained in this Section
are in addition to any liability that the  Indemnifying  Parties may have to the
Indemnified Parties.

      6. Miscellaneous.

            (a)  Remedies.  In the  event of a  breach  by the  Company  or by a
Holder,  of any of their  obligations  under this Agreement,  each Holder or the
Company,  as the case may be, in  addition to being  entitled  to  exercise  all
rights granted by law and under this Agreement,  including  recovery of damages,
will be entitled to specific performance of its rights under this Agreement. The
Company and each Holder agree that monetary  damages would not provide  adequate
compensation  for any losses  incurred by reason of a breach by it of any of the
provisions of this Agreement and hereby further agrees that, in the event of any
action for specific  performance  in respect of such breach,  it shall waive the
defense that a remedy at law would be adequate.

            (b) No Piggyback on  Registrations.  Except as set forth on Schedule
6(b)(i),  neither the Company nor any of its  security  holders  (other than the
Holders in such capacity pursuant hereto) may include  securities of the Company
in a  Registration  Statement  filed pursuant to Section 2 hereof other than the
Registrable Securities. Except as set forth on Schedule 6(b)(ii) or as set forth
in the SEC  Reports,  no Person  has any right to cause the  Company to effect a
registration  under the Securities  Act of any securities of the Company.  Other
than a  Registration  Statement on Form S-8, the Company  shall not and will not
file any other registration statement until after the Effective Date.

                                      -9-
<PAGE>

            (c) Compliance. Each Holder covenants and agrees that it will comply
with the prospectus delivery requirements of the Securities Act as applicable to
it  in  connection  with  sales  of  Registrable   Securities  pursuant  to  the
Registration Statement.

            (d) Discontinued Disposition.  Each Holder agrees by its acquisition
of such  Registrable  Securities that, upon receipt of a notice from the Company
of the  occurrence  of any event of the kind  described  in Section  3(c),  such
Holder will forthwith  discontinue  disposition of such  Registrable  Securities
under the  Registration  Statement until such Holder's  receipt of the copies of
the supplemented Prospectus and/or amended Registration Statement or until it is
advised in writing (the  "Advice") by the Company that the use of the applicable
Prospectus  may be resumed,  and, in either  case,  has  received  copies of any
additional  or  supplemental  filings  that are  incorporated  or  deemed  to be
incorporated  by reference in such  Prospectus or  Registration  Statement.  The
Company may provide  appropriate  stop orders to enforce the  provisions of this
paragraph.

            (e) Piggyback Registrations. If at any time during the Effectiveness
Period  there is not an  effective  Registration  Statement  covering all of the
Registrable  Securities and the Company shall determine to prepare and file with
the  Commission  a  registration  statement  relating to an offering for its own
account or the account of others under the  Securities  Act of any of its equity
securities,  other than on Form S-4 or Form S-8 (each as  promulgated  under the
Securities Act) or their then  equivalents  relating to equity  securities to be
issued solely in connection  with any  acquisition  of any entity or business or
equity  securities  issuable in connection  with stock option or other  employee
benefit  plans,  then the Company shall send to each Holder a written  notice of
such  determination  and,  if within  fifteen  (15) days  after the date of such
notice,  any such Holder shall so request in writing,  the Company shall include
in such  registration  statement all or any part of such Registrable  Securities
such Holder requests to be registered, subject to customary underwriter cutbacks
applicable to all holders of "piggyback" registration rights; provided, however,
that (i) if, at any time after giving written notice of is intention to register
any  securities and prior to the effective  date of the  registration  statement
filed in  connection  with such  registration,  the Company  determines  for any
reason not to proceed with such registration,  the Company may, at its election,
given written notice of such determination to the Holders and,  thereupon,  will
be  relieved  of its  obligation  to  register  any  Registrable  Securities  in
connection with such  registration,  and (ii) in case of a determination  by the
Company to delay  registration of its securities,  the Company will be permitted
to delay the  registration of Registrable  Securities for the same period as the
delay in  registering  such other  securities.  Notwithstanding  the  foregoing,
nothing in this  paragraph  (e) shall permit the Company to file a  registration
statement in contravention of the restrictions in Section 6(b)

            (f)  Amendments  and  Waivers.  The  provisions  of this  Agreement,
including  the  provisions  of this  sentence,  may not be amended,  modified or
supplemented,  and waivers or consents to departures from the provisions  hereof
may not be given,  unless the same shall be in writing and signed by the Company
and each Holder of the then outstanding Registrable Securities.

            (g)  Notices.  Any  and  all  notices  or  other  communications  or
deliveries  required or permitted to be provided  hereunder  shall be in writing
and  shall be deemed  given and

                                      -10-
<PAGE>

effective  on the  earliest of (i) the date of  transmission,  if such notice or
communication  is delivered via facsimile at the facsimile  number  provided for
below prior to 5:00 p.m. (New York City time) on a Trading Day, (ii) the Trading
Day after the date of transmission, if such notice or communication is delivered
via  facsimile at the facsimile  number  provided for below later than 5:00 p.m.
(New York City time) on any date,  (iii) the Trading Day  following  the date of
mailing,  if sent by nationally  recognized  overnight courier service,  or (iv)
upon  actual  receipt by the party to whom such  notice is required to be given.
The address for such notices and communications shall be delivered and addressed
as set forth in the Purchase Agreement.

            (h)  Successors  and  Assigns.  This  Agreement  shall  inure to the
benefit of and be binding upon the successors  and permitted  assigns of each of
the  parties  and shall  inure to the  benefit of each  Holder.  Each Holder may
assign  their  respective  rights  hereunder in the manner and to the Persons as
permitted under the Purchase Agreement.

            (i) Execution and  Counterparts.  This  Agreement may be executed in
any number of counterparts, each of which when so executed shall be deemed to be
an original and, all of which taken together  shall  constitute one and the same
Agreement.   In  the  event  that  any   signature  is  delivered  by  facsimile
transmission,  such  signature  shall create a valid  binding  obligation of the
party  executing  (or on whose behalf such  signature is executed) the same with
the same  force and  effect as if such  facsimile  signature  were the  original
thereof.

            (j) Governing Law. This Agreement shall be governed by and construed
in accordance  with the internal laws of the State of New York without regard to
the conflicts of laws principles thereof.  The parties hereto hereby irrevocably
agree that any suit or proceeding arising directly and/or indirectly pursuant to
or under this  Agreement,  shall be brought  solely in a federal or state  court
located in the City, County and State of New York. By its execution hereof,  the
parties hereby covenant and irrevocably  submit to the in personam  jurisdiction
of the federal  and state  courts  located in the City,  County and State of New
York and agree  that any  process in any such  action may be served  upon any of
them  personally,  or by certified  mail or  registered  mail upon them or their
agent,  return  receipt  requested,  with the same full  force and  effect as if
personally served upon them in New York City. The parties hereto waive any claim
that  any such  jurisdiction  is not a  convenient  forum  for any such  suit or
proceeding  and any defense or lack of in  personam  jurisdiction  with  respect
thereto.  In the event of any such action or  proceeding,  the party  prevailing
therein  shall be  entitled  to  payment  from the  other  party  hereto  of its
reasonable counsel fees and disbursements in an amount judicially determined.

            (k) Cumulative Remedies. The remedies provided herein are cumulative
and not exclusive of any remedies provided by law.

            (l) Severability. If any term, provision, covenant or restriction of
this  Agreement  is held by a court of  competent  jurisdiction  to be  invalid,
illegal,  void  or  unenforceable,  the  remainder  of  the  terms,  provisions,
covenants  and  restrictions  set forth  herein  shall  remain in full force and
effect and shall in no way be affected, impaired or invalidated, and the parties
hereto  shall use their  commercially  reasonable  efforts to find and employ an
alternative  means to achieve the same or substantially  the same result as that
contemplated  by such term,  provision,  covenant or  restriction.  It is hereby
stipulated  and declared to be the

                                      -11-
<PAGE>

intention of the parties  that they would have  executed  the  remaining  terms,
provisions, covenants and restrictions without including any of such that may be
hereafter declared invalid, illegal, void or unenforceable.

            (m) Headings.  The headings in this Agreement are for convenience of
reference only and shall not limit or otherwise affect the meaning hereof.

            (n) Independent  Nature of Purchasers'  Obligations and Rights.  The
obligations  of each  Purchaser  hereunder  is  several  and not joint  with the
obligations  of any  other  Purchaser  hereunder,  and  no  Purchaser  shall  be
responsible  in any way for the  performance  of the  obligations  of any  other
Purchaser  hereunder.  Nothing  contained  herein or in any other  agreement  or
document delivered at any closing, and no action taken by any Purchaser pursuant
hereto  or  thereto,   shall  be  deemed  to  constitute  the  Purchasers  as  a
partnership,  an  association,  a joint venture or any other kind of entity,  or
create a presumption  that the  Purchasers are in any way acting in concert with
respect to such obligations or the transactions  contemplated by this Agreement.
Each  Purchaser  shall be entitled to protect and enforce its rights,  including
without limitation the rights arising out of this Agreement, and it shall not be
necessary  for any other  Purchaser to be joined as an  additional  party in any
proceeding for such purpose.

            (o)  Obligation  of Holders to Furnish  Information.  The  Company's
obligation  to  cause  any  Registration  Statement  to be filed  and/or  become
effective in connection with distribution of any Registrable Securities pursuant
to this Agreement is contingent upon each Holder,  with  reasonable  promptness,
furnishing to the Company such  information  regarding  itself,  the Registrable
Securities  held  by  it,  and  the  intended  method  of  disposition  of  such
securities,  as is required  pursuant to Regulation  S-K  promulgated  under the
Securities Act, to effect the registration of the Registrable  Securities.  Each
Holder agrees, by acquisition of the Registration Securities,  that it shall not
be  entitled  to  sell  any  of  such  Registrable  Securities  pursuant  to the
Registration Statement or to receive a Prospectus relating thereto,  unless such
Holder has furnished the Company with all  information  required to be disclosed
in order to make any information  regarding such Holder previously  furnished to
the Company by such Holder, and any other information  regarding such Holder and
the distribution of such Holder's Registrable Securities as the Company may from
time to time reasonably request,  not misleading in a material respect. Any sale
of any Registrable  Securities by any Holder shall  constitute a  representation
and warranty by such Holder that the information relating to such Holder and its
plan of distribution is as set forth in the prospectus  delivered by such Holder
in connection  with such  disposition,  that such  Prospectus does not as of the
time of such sale contain any untrue statement of a material fact relating to or
provided by such Holder or  relating to its plan of  distribution  and that such
Prospectus  does not as of the time of such sale omit to state any material fact
relating to or  provided by such Holder or relating to its plan of  distribution
necessary  to  make  the  statements  in  such  Prospectus,   in  light  of  the
circumstances under which they were made, not misleading.

                  [Remainder of page intentionally left blank]

                                      -12-
<PAGE>

      IN WITNESS  WHEREOF,  the parties have executed this  Registration  Rights
Agreement as of the date first written above.

                                           DYNTEK, INC.

                                           By:
                                              ----------------------------------
                                                 Steven Ross
                                                 Chief Executive Officer

                                      -13-
<PAGE>

          (PURCHASERS SIGNATURE PAGE TO REGISTRATION RIGHTS AGREEMENT)

                                          [                                    ]
                                           ------------------------------------

                                          By:
                                             ----------------------------------
                                                Name:
                                                Title:

                                          [                                    ]
                                           ------------------------------------

                                          By:
                                             ----------------------------------
                                                Name:
                                                Title:

                                          [                                    ]
                                           ------------------------------------

                                          By:
                                             ----------------------------------
                                                Name:
                                                Title:

<PAGE>

                                     ANNEX A

Plan of Distribution

      The  Selling  Stockholders  and  any  of  their  pledgees,  assignees  and
successors-in-interest  may, from time to time,  sell any or all of their shares
of Common Stock on any stock exchange,  market or trading  facility on which the
shares  are traded or in private  transactions.  These  sales may be at fixed or
negotiated  prices.  The  Selling  Stockholders  may  use any one or more of the
following methods when selling shares:

      o     ordinary  brokerage  transactions  and  transactions  in  which  the
            broker/dealer solicits purchasers;

      o     block  trades in which the  broker/dealer  will  attempt to sell the
            shares as agent but may  position  and resell a portion of the block
            as principal to facilitate the transaction;

      o     purchases  by  a  broker/dealer  as  principal  and  resale  by  the
            broker/dealer for its account;

      o     an  exchange  distribution  in  accordance  with  the  Rules  of the
            applicable exchange;

      o     privately negotiated transactions;

      o     settlement of short sales;

      o     broker/dealers  may agree with the  Selling  Stockholders  to sell a
            specified number of such shares at a stipulated price per share;

      o     a combination of any such methods of sale; and

      o     any other method permitted pursuant to applicable law.

      The Selling  Stockholders  may also sell  shares  under Rule 144 under the
Securities Act, if available, rather than under this prospectus.

      Broker/dealers  engaged by the Selling  Stockholders may arrange for other
brokers/dealers to participate in sales.  Broker/dealers may receive commissions
from the Selling  Stockholders (or, if any  broker/dealer  acts as agent for the
purchaser  of shares,  from the  purchaser)  in amounts  to be  negotiated.  The
Selling Stockholders do not expect these commissions to exceed what is customary
in the types of transactions involved.
<PAGE>

      The Selling  Stockholders may from time to time pledge or grant a security
interest in some or all of the shares of common stock owned by them and, if they
default in the performance of their secured obligations, the pledgees or secured
parties  may offer and sell the  shares of common  stock from time to time under
this  prospectus,  or under an amendment to this prospectus under Rule 424(b)(3)
or other applicable provision of the Securities Act of 1933 amending the list of
Selling  Stockholders to include the pledgee,  transferee or other successors in
interest as Selling Stockholders under this prospectus.

      The  Selling  Stockholders  and any  broker/dealers  or  agents  that  are
involved  in selling  the shares may be deemed to be  "underwriters"  within the
meaning of the Securities Act in connection with such sales. In such event,  any
commissions  received  by such  broker/dealers  or agents  and any profit on the
resale  of the  shares  purchased  by  them  may be  deemed  to be  underwriting
commissions under the Securities Act. The Selling Stockholders have informed the
Company  that it does not have  any  agreement  or  understanding,  directly  or
indirectly, with any person to distribute the Common Stock.

      The  Company is  required  to pay all fees and  expenses  incident  to the
registration  of the shares.  The Company  has agreed to  indemnify  the Selling
Stockholders against certain losses, claims, damages and liabilities,  including
liabilities under the Securities Act.

                                      -2-
<PAGE>

                               Schedule 6.1(b)(i)

                          Form S-3 Selling Stockholders

      Name                                                         Shares
      ---------------------------------------                    ---------
      21st Century Investor LLC                                    120,000
      Adams, Donald                                              1,440,000
      Adkins, Douglas                                              840,000
      Alec Balestra Irrevocable Trust                              138,000
      Armitage, Barclay M                                          240,000
      Assante, Michael J                                           300,000
      Attanasi, Louis J                                             60,000
      Barnet Resnick Trust                                         120,000
      Becker, Martin                                                60,000
      Ben-Yishay, Arie                                             180,000
      Berg, Jack                                                   120,000
      Bergstein, Jay                                                60,000
      Bindseil, Edwin R                                             60,000
      Blockstein, David                                             24,000
      Bradley, Charles                                              60,000
      Broadband Capital Management                                 360,000
      Brunnschweiler, Christian and Erika                          153,000
      C. Peter Clapp Revocable Trust                               237,600
      Cabral, Raymond P                                             60,000
      Calcagno, Salvatore                                           68,000
      Carter, Jeffrey                                               60,000
      Castrovinci, Louis                                            48,000
      Cocke, Gregory (South West Securities as IRA Custodian)      345,600
      Cocke, Gregory and Susan                                     771,800
      Cocke, Susan (South West Securities as IRA Custodian)         64,800
      Cohen, Richard                                               240,000
      Cosentino, Samuel                                            100,000
      De Cresenzo, Al                                               24,000
      DeSimone, Dominick                                           414,400
      Ditri, Arnold                                                240,000
      Drucker, Mel                                                  71,400
      Duncan Capital LLC                                           466,667
      Erlanger, Jack                                                60,000
      Filon, William                                                60,000
      Finkle, S. Marcus                                            120,000
      Giaccio, John                                                 34,000
      Gillings, Robert                                              37,400
      Grinbaum, Mark and Tatyana                                    60,000
      H.T. Ardinger                                                 75,758
      Hansen, J. Burke                                              60,000
      Harms, William H                                             240,000
      Heim, William                                                100,800
      Inskip, Harold                                                60,000
      Iverson, Anita                                                90,000

                                      -3-
<PAGE>

      Name                                                         Shares
      ---------------------------------------                    ---------
      Justin Balestra Irrevocable Trust                            138,000
      King, Christopher and Michele                                261,830
      Lange, Daniel and Claire                                      60,000
      Laurus Master Fund, Ltd.                                   4,313,889
      Leviticus Partners LP                                        600,000
      Lisyansky, Alexander                                          84,000
      Lyons , Frank                                                120,000
      Mahler, Richard                                               24,000
      Maltese, Robert                                              204,000
      Marks, Fredric                                                14,000
      McGregor, Dan                                                102,000
      Meshel, Jeffrey                                              120,000
      Montalbine, Robert                                            78,000
      MSR Consultants                                              227,273
      Murello, Robert                                               60,000
      Onischenko,Tarras                                             24,000
      Page, Neil                                                    36,000
      Pericelli, Louis                                              24,000
      Philip L. Byrnes Trust                                        60,000
      Puccio, Frederick J                                          300,000
      Puccio, Jr., Gerry                                           420,000
      Puma, Joseph                                               1,071,200
      Rabito, Louis and Anthony Agresti                             24,000
      RBD Limited                                                  240,000
      Realty Appraisal Defined Benefit Pension Plan                 78,000
      RH Damon & Co.                                             2,067,692
      Roschwalb, Arthur                                             48,000
      Rosenbaum, Michael                                           480,000
      Ruggieri, David                                              600,000
      Ruggieri, David and Victoria                                 227,273
      Russ, Kenneth and Joanne                                      78,000
      Russ, Linda                                                   12,000
      Scamardella, John                                            720,000
      Serrano, Joseph and Pilar                                    251,600
      Sharkey, Kenneth                                              60,000
      Silvaslian, Peter K                                          120,000
      Silvaslian, Peter K. and Lillian                             290,000
      Sunderman Setty MD Trust                                     120,000
      Trimble, Russell H. and Setsuko I                            120,000
      Trust for the Young Family                                   120,000
      Valko, Steven J                                              189,600
      Vega, Ricardo                                                 69,600
      Vingan, Roy                                                  120,000
      Welch, Herbert                                               347,854
      William Armitage Trust                                       240,000
      Williamson, Lee A                                            360,000
      Total                                                     23,871,036
                                                                ==========

                                      -4-
<PAGE>

                                Schedule 6(b)(ii)

------------------------------------------------------------------------------
  Name                                                          Shares
------------------------------------------------------------------------------

------------------------------------------------------------------------------

------------------------------------------------------------------------------

                                      -5-Exhibit 4.3

NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE
HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE
SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM
REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES
ACT"), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN
EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN
AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION
REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE
SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO
SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE
COMPANY. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS
SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER
LOAN SECURED BY SUCH SECURITIES

                                  DYNTEK, INC.

           SERIES A WARRANT TO PURCHASE ______ SHARES OF COMMON STOCK

                             (SUBJECT TO ADJUSTMENT)

                         (Void after October ___, 2009)

PPW -

      THIS SERIES A COMMON STOCK  PURCHASE  WARRANT  CERTIFIES  that,  for value
received,  _____________ (the "Holder"), is entitled, upon the terms and subject
to the limitations on exercise and the conditions  hereinafter set forth, at any
time on or after  [INSERT  DATE  THAT IS SIX  MONTHS  FROM  CLOSING],  2004 (the
"Initial  Exercise  Date") and on or prior to the close of  business  on [INSERT
DATE THAT IS 5 YEARS  FROM SIX MONTHS  AFTER  CLOSING],  2009 (the  "Termination
Date") but not  thereafter,  to subscribe for and purchase from DynTek,  Inc., a
Delaware  corporation  (the  "Company"),  up to  ____________  [30% OF SHARES OF
COMMON  STOCK SO  PURCHASED]  shares  (the  "Warrant  Shares") of Class A Common
Stock,  $.0001 par value per share,  of the Company  (the "Common  Stock").  The
purchase  price of one share of Common Stock (the  "Exercise  Price") under this
Warrant shall be $1.75, subject to adjustment hereunder.  The Exercise Price and
the number of  Warrant  Shares for which the  Warrant  is  exercisable  shall be
subject  to  adjustment  as  provided  herein.  Capitalized  terms  used and not
otherwise  defined  herein  shall have the  meanings  set forth in that  certain
Securities  Purchase Agreement dated April __, 2004, between the Company and the
purchasers set forth on Schedule 1 thereto (the "Purchase Agreement").
<PAGE>
                                      -2-

      1.  Title  to  Warrant.  Prior to the  Termination  Date  and  subject  to
compliance with applicable laws and Section 7 of this Warrant,  this Warrant and
all rights  hereunder  are  transferable,  in whole or in part, at the office or
agency of the  Company by the Holder in person or by duly  authorized  attorney,
upon surrender of this Warrant  together with the Assignment Form annexed hereto
properly  endorsed.  The transferee shall sign an investment  letter in form and
substance reasonably satisfactory to the Company.

      2.  Authorization of Shares. The Company covenants that all Warrant Shares
which may be issued upon the exercise of the purchase rights represented by this
Warrant will, upon exercise of the purchase rights  represented by this Warrant,
be duly authorized,  validly issued,  fully paid and nonassessable and free from
all taxes,  liens and charges in respect of the issue thereof  (other than taxes
in respect of any transfer occurring contemporaneously with such issue).

      3. Exercise of Warrant.

            (a) Exercise of the purchase rights  represented by this Warrant may
be made at any time or times on or after  the  Initial  Exercise  Date and on or
before the  Termination  Date by the surrender of this Warrant and the Notice of
Exercise  Form annexed  hereto duly  executed,  at the office of the Company (or
such  other  office or agency of the  Company as it may  designate  by notice in
writing to the registered  Holder at the address of such Holder appearing on the
books of the  Company),  and upon payment of the  Exercise  Price of the Warrant
Shares thereby  purchased by wire transfer or cashier's  check drawn on a United
States bank or by means of a cashless  exercise  pursuant to Section  3(d),  the
Holder  shall be  entitled  to receive a  certificate  for the number of Warrant
Shares so purchased.  Certificates for Warrant Shares purchased  hereunder shall
be delivered to the Holder  within five (5) Trading Days after the date on which
this Warrant  shall have been  exercised  as  aforesaid.  This Warrant  shall be
deemed to have been  exercised and such  certificate  or  certificates  shall be
deemed to have been issued,  and the Holder or any other person so designated to
be named  therein  shall be  deemed  to have  become a holder  of record of such
shares for all purposes,  as of the date the Warrant has been properly exercised
by payment to the  Company of the  Exercise  Price and all taxes  required to be
paid by the  Holder,  if any,  pursuant  to  Section 5 have been  paid.  If such
conditions  by the Holder have been met, and the Company fails to deliver to the
Holder a certificate or certificates representing the Warrant Shares pursuant to
this Section 3(a) by the close of business on the 5th Trading Day after the date
of such conditions being met by the Holder,  then the Holder will have the right
to rescind  such  exercise.  In addition to any other  rights  available  to the
Holder,  if the  Company  fails  to  deliver  to the  Holder  a  certificate  or
certificates  representing the Warrant Shares pursuant to a proper exercise, and
all  conditions  being met by the  Holder,  by the close of  business on the 8th
Trading  Day after the date of  exercise,  and if after such 8th Trading Day the
Holder is required by its broker to purchase (in an open market  transaction  or
otherwise)  shares of Common Stock to deliver in  satisfaction  of a sale by the
Holder of the Warrant  Shares which the Holder  anticipated  receiving upon such
exercise (a "Buy-In"),  then the Company shall (1) pay in immediately  available
funds to the Holder the amount by which (x) the Holder's  total  purchase  price
(including  brokerage  commissions,  if any) for the Warrant Shares so purchased
exceeds (y) the amount  obtained by multiplying (A) the number of Warrant Shares
that the Company was  required to deliver to the Holder in  connection  with the
exercise  at issue  times (B) the price at
<PAGE>
                                      -3-

which the sell order giving rise to such purchase  obligation was executed,  and
(2) at the option of the Holder, either reinstate the portion of the Warrant and
equivalent  number of Warrant  Shares for which such exercise was not honored or
deliver to the Holder the number of shares of Common  Stock that would have been
issued  had  the  Company  timely   complied  with  its  exercise  and  delivery
obligations hereunder.  For example, if the Holder purchases Common Stock having
a total  purchase  price of $100 to cover a Buy-In with  respect to an attempted
exercise of Warrant  Shares  with an  aggregate  sale price  giving rise to such
purchase  obligation  of $80,  under  clause  (1) of the  immediately  preceding
sentence  the Company  shall be required to pay the Holder $20. The Holder shall
provide the Company written notice  indicating the amounts payable to the Holder
in respect of the  Buy-In,  together  with  applicable  confirmations  and other
evidence  reasonably  requested  by the  Company.  Nothing  herein shall limit a
Holder's right to pursue any other remedies available to it hereunder, at law or
in equity including, without limitation, a decree of specific performance and/or
injunctive  relief  with  respect to the  Company's  failure  to timely  deliver
certificates  representing  Warrant  Shares as  required  pursuant  to the terms
hereof.

            (b) If this Warrant shall have been  exercised in part,  the Company
shall, at the time of delivery of the  certificate or certificates  representing
Warrant Shares,  deliver to Holder a new Warrant evidencing the rights of Holder
to purchase the unpurchased Warrant Shares called for by this Warrant, which new
Warrant shall in all other respects be identical with this Warrant.

            (c) The Company shall not effect any exercise of this  Warrant,  and
the Holder  shall not have the right to exercise  any  portion of this  Warrant,
pursuant to Section 3(a) or otherwise, to the extent that after giving effect to
such  issuance  after   exercise,   the  Holder   (together  with  the  Holder's
Affiliates),   as  set  forth  on  the  applicable  Notice  of  Exercise,  would
beneficially  own in excess of 4.9% of the number of shares of the Common  Stock
issued and  outstanding  immediately  after giving effect to such issuance.  For
purposes  of the  foregoing  sentence,  the  number of  shares  of Common  Stock
beneficially  owned by the Holder and its Affiliates shall include the number of
shares of Common Stock  issuable  upon  exercise of this Warrant with respect to
which the  determination  of such sentence is being made,  but shall exclude the
number of shares of Common  Stock which would be issuable  upon (A)  exercise of
the remaining,  nonexercised  portion of this Warrant  beneficially owned by the
Holder  or  any  of  its  Affiliates  and  (B)  exercise  or  conversion  of the
unexercised  or  nonconverted  portion of any other  securities  of the  Company
(including,  without limitation,  any other Warrants) subject to a limitation on
conversion or exercise analogous to the limitation contained herein beneficially
owned  by the  Holder  or any of its  Affiliates.  Except  as set  forth  in the
preceding  sentence,  for purposes of this Section  3(c),  beneficial  ownership
shall be calculated  in  accordance  with Section 13(d) of the Exchange Act. For
purposes of this Section 3(c), in determining  the number of outstanding  shares
of Common  Stock,  the Holder may rely on the  number of  outstanding  shares of
Common  Stock as reflected  in (x) the  Company's  most recent Form 10-Q or Form
10-K, as the case may be, (y) a more recent public  announcement  by the Company
or (z) any other notice by the Company or the Company's  transfer  agent setting
forth the number of shares of Common Stock outstanding. Upon the written or oral
request of the Holder,  the Company shall within two Trading Days confirm orally
and in  writing  to the  Holder  the  number  of shares  of  Common  Stock  then
outstanding.  In any case,  the number of  outstanding  shares of Company Common
Stock shall be determined  after giving effect to the  conversion or exercise of
securities  of  the  Company,  including  this  Warrant,  by the  Holder  or its
Affiliates  since  the date
<PAGE>
                                      -4-

as of which such number of outstanding shares of Common Stock was reported.  The
provisions  of this  Section  3(c) may be  waived  by the  Holder  upon,  at the
election of the Holder, not less than 61 days' prior notice to the Company,  and
the  provisions of this Section 3(c) shall continue to apply until such 61st day
(or such later date, as  determined  by the Holder,  as may be specified in such
notice  of  waiver).  The  Holder  is solely  responsible  for all  calculations
required in this  Section  3(c).  The Company  shall have no  liability  for any
issuances  of  Warrant  Shares  that  exceed  the 5% amount  and the  Company is
entitled  to rely on all  calculations  by the  Holder  and/or its  agents.  The
Holder's exercise notice shall be deemed a representation of the Holder that the
number of Warrant Shares to be acquired  pursuant to such exercise  notice shall
be in compliance with the provisions of this Section 3(c).

            (d) If,  but only if,  at any time  after  one year from the date of
issuance  of  this  Warrant  there  is  no  effective   Registration   Statement
registering  the resale of the Warrant  Shares by the Holder,  this  Warrant may
also be  exercised  at such time by means of a "cashless  exercise" in which the
Holder  shall be  entitled  to receive a  certificate  for the number of Warrant
Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:

      (A) = the  Closing  Price on the Trading  Day  preceding  the date of such
            election;

      (B) = the Exercise Price of the Warrants, as adjusted; and

      (X) = the number of Warrant Shares  issuable upon exercise of the Warrants
            in accordance with the terms of this Warrant.

      4.  No  Fractional   Shares  or  Scrip.  No  fractional  shares  or  scrip
representing  fractional  shares  shall  be  issued  upon the  exercise  of this
Warrant.  As to any fraction of a share which Holder would otherwise be entitled
to purchase  upon such  exercise,  the Company  shall pay a cash  adjustment  in
respect of such final fraction in an amount equal to such fraction multiplied by
the Exercise Price.

      5.  Charges,  Taxes and  Expenses.  Issuance of  certificates  for Warrant
Shares shall be made without  charge to the Holder for any issue or transfer tax
or other incidental expense in respect of the issuance of such certificate,  all
of which taxes and expenses shall be paid by the Company,  and such certificates
shall be  issued  in the name of the  Holder  or in such name or names as may be
directed by the Holder;  provided,  however,  that in the event certificates for
Warrant  Shares are to be issued in a name  other  than the name of the  Holder,
this  Warrant  when  surrendered  for  exercise  shall  be  accompanied  by  the
Assignment Form attached hereto duly executed by the Holder; and the Company may
require, as a condition thereto, the payment of a sum sufficient to reimburse it
for any transfer tax incidental thereto.

      6. Closing of Books.  The Company will not close its stockholder  books or
records in any  manner  which  prevents  the timely  exercise  of this  Warrant,
pursuant to the terms hereof.
<PAGE>
                                      -5-

      7. Transfer, Division and Combination.

            (a) Subject to compliance  with any applicable  securities  laws and
the  conditions  set  forth in  Section 1 and  Section  7(e)  hereof  and to the
provisions of Section 4.1 of the Purchase Agreement, this Warrant and all rights
hereunder are transferable,  in whole or in part, upon surrender of this Warrant
at the principal  office of the Company,  together with a written  assignment of
this Warrant  substantially  in the form  attached  hereto duly  executed by the
Holder or its agent or attorney and funds  sufficient to pay any transfer  taxes
payable upon the making of such transfer.  Upon such surrender and, if required,
such payment, the Company shall execute and deliver a new Warrant or Warrants in
the name of the assignee or assignees and in the  denomination or  denominations
specified in such  instrument of  assignment,  and shall issue to the assignor a
new Warrant  evidencing  the portion of this Warrant not so  assigned,  and this
Warrant shall promptly be cancelled.  A Warrant,  if properly  assigned,  may be
exercised by a new holder for the purchase of Warrant  Shares  without  having a
new Warrant issued.

            (b) This Warrant may be divided or combined with other Warrants upon
presentation  hereof at the  aforesaid  office of the Company,  together  with a
written notice  specifying the names and denominations in which new Warrants are
to be  issued,  signed  by the  Holder  or its  agent or  attorney.  Subject  to
compliance  with Section 7(a), as to any transfer  which may be involved in such
division or combination,  the Company shall execute and deliver a new Warrant or
Warrants  in  exchange  for the Warrant or Warrants to be divided or combined in
accordance with such notice.

            (c) The Company shall prepare,  issue and deliver at its own expense
(other than transfer taxes) the new Warrant or Warrants under this Section 7.

            (d) The Company agrees to maintain,  at its aforesaid office,  books
for the registration and the registration of transfer of the Warrants.

            (e) If, at the time of the  surrender of this Warrant in  connection
with any transfer of this  Warrant,  the  transfer of this Warrant  shall not be
registered pursuant to an effective  registration statement under the Securities
Act and under  applicable  state  securities  or blue sky laws,  the Company may
require,  as a  condition  of  allowing  such  transfer  (i) that the  Holder or
transferee of this Warrant, as the case may be, furnish to the Company a written
opinion  of  counsel  (which  opinion  shall be in  form,  substance  and  scope
customary for opinions of counsel in comparable transactions) to the effect that
such  transfer may be made without  registration  under the  Securities  Act and
under  applicable  state  securities  or blue sky laws,  (ii) that the holder or
transferee  execute and deliver to the Company an investment  letter in form and
substance  acceptable  to the  Company  and  (iii)  that  the  transferee  be an
"accredited investor" as defined in Rule 501(a) promulgated under the Securities
Act.

      8. No Rights as Shareholder Until Exercise.  This Warrant does not entitle
the Holder to any voting rights or other rights as a shareholder  of the Company
prior to the exercise hereof. Upon the surrender of this Warrant and the payment
of the  aggregate  Exercise  Price  (or by means of a  cashless  exercise),  the
Warrant  Shares so purchased  shall be and be deemed to be
<PAGE>
                                      -6-

issued to such  Holder  as the  record  owner of such  shares as of the close of
business on the later of the date of such surrender or payment.

      9.  Loss,  Theft,  Destruction  or  Mutilation  of  Warrant.  The  Company
covenants that upon receipt by the Company of evidence  reasonably  satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock
certificate  relating  to the  Warrant  Shares,  and in case of  loss,  theft or
destruction,  of indemnity or security reasonably  satisfactory to it (which, in
the case of the  Warrant,  shall not include the posting of any bond),  and upon
surrender and cancellation of such Warrant or stock  certificate,  if mutilated,
the Company  will make and deliver a new  Warrant or stock  certificate  of like
tenor  and  dated  as of such  cancellation,  in lieu of such  Warrant  or stock
certificate.

      10. Saturdays,  Sundays,  Holidays,  etc. If the last or appointed day for
the  taking of any action or the  expiration  of any right  required  or granted
herein shall be a Saturday,  Sunday or a legal holiday in the State of New York,
then  such  action  may be  taken or such  right  may be  exercised  on the next
succeeding day not a Saturday, Sunday or legal holiday in the State of New York.

      11. Adjustments to Exercise Price and Number of Warrant Shares.

      For purposes of this Section 11,  references to Common Stock shall include
shares of Class B Common  Stock,  par value $.0001 of the Company (and any other
classes of common  stock  issued by the  Company).  References  to Common  Stock
Equivalents shall include Convertible  Securities (as defined below) and Options
(as defined below).

            (a) Stock Splits, Etc. The number and kind of securities purchasable
upon the  exercise of this  Warrant and the  Exercise  Price shall be subject to
adjustment from time to time upon the happening of any of the following. In case
the  Company  shall (i) pay a  dividend  in  shares  of  Common  Stock or make a
distribution  in shares of Common  Stock to  holders of its  outstanding  Common
Stock,  (ii)  subdivide  its  outstanding  shares of Common Stock into a greater
number of shares,  (iii) combine its  outstanding  shares of Common Stock into a
smaller  number  of  shares of Common  Stock,  or (iv)  issue any  shares of its
capital  stock in a  reclassification  of the Common  Stock,  then the number of
Warrant  Shares  purchasable  upon  exercise of this Warrant  immediately  prior
thereto  shall be adjusted  so that the Holder  shall be entitled to receive the
kind and number of Warrant  Shares or other  securities  of the Company which it
would  have  owned or have  been  entitled  to  receive  had such  Warrant  been
exercised in advance  thereof.  Upon each such adjustment of the kind and number
of Warrant  Shares or other  securities  of the  Company  which are  purchasable
hereunder  pursuant  to this  Section  11(a),  the Holder  shall  thereafter  be
entitled to purchase the number of Warrant Shares or other securities  resulting
from such  adjustment at an Exercise  Price per Warrant Share or other  security
obtained by multiplying the Exercise Price in effect  immediately  prior to such
adjustment  by  the  number  of  Warrant  Shares  purchasable   pursuant  hereto
immediately  prior to such  adjustment  and  dividing  by the  number of Warrant
Shares or other  securities of the Company  resulting from such  adjustment.  An
adjustment  made pursuant to this paragraph shall become  effective  immediately
after the effective  date of such event  retroactive to the record date, if any,
for such event.
<PAGE>
                                      -7-

            (b) Anti-Dilution  Provisions.  From the Initial Exercise Date until
one year  following  the  Closing  Date,  the  Exercise  Price and the number of
Warrant Shares issuable hereunder and for which this Warrant is then exercisable
pursuant to Section 1 hereof shall be subject to adjustment from time to time as
provided in this Section 11(b). In the event that any adjustment of the Exercise
Price as required  herein  results in a fraction of a cent,  such Exercise Price
shall be rounded up or down to the nearest cent.

                  (i) Adjustment of Exercise  Price. If and whenever the Company
issues or sells,  or in  accordance  with this Section 11(b) hereof is deemed to
have issued or sold,  any shares of Common Stock for a  consideration  per share
less than the then Exercise Price or for no consideration (such lower price, the
"Base Share  Price" and such  issuances  collectively,  a "Dilutive  Issuance"),
then, the Exercise Price shall be reduced to a price equal to the greater of (i)
the Closing Price on the date the Securities  Purchase Agreement is executed and
delivered by all parties thereto, and (ii) the quotient obtained by dividing (1)
an  amount  equal to the sum of (a) the total  number of shares of Common  Stock
outstanding immediately prior to such issuance, multiplied by the Exercise Price
in effect immediately prior to such issuance, and (b) the consideration received
by the Company upon such  issuance,  by (2) the total number of shares of Common
Stock  outstanding  immediately  after the issuance of such Common Stock (as set
forth in this clause (ii), the "Quotient");  provided, that for purposes hereof,
all shares of Common  Stock  that are  issuable  upon  conversion,  exercise  or
exchange of Common Stock  Equivalents  shall be deemed  outstanding  immediately
after the issuance of such Common Stock  Equivalents.  Such adjustment  shall be
made  whenever  such  shares of Common  Stock or Common  Stock  Equivalents  are
issued. Upon each adjustment of the Exercise Price pursuant to the provisions of
this Section,  the number of Warrant  Shares  issuable upon the exercise of each
Warrant  shall be adjusted to the nearest  full amount by  multiplying  a number
equal to the Exercise Price in effect  immediately  prior to such  adjustment by
the number of Warrant Shares issuable upon exercise of the Warrants  immediately
prior to such  adjustment  and dividing the product so obtained by the Quotient;
provided,  however, that in no event shall additional Warrant Shares be issuable
pursuant to this subsection (i) where, after giving effect to such issuance, the
Holder (together with the Holder's  Affiliates) would beneficially own in excess
of 19.9% of the number of shares of the  Common  Stock  issued  and  outstanding
immediately after giving effect to such issuance.

                  (ii) Effect on Exercise Price of Certain Events.  For purposes
of  determining  the adjusted  Exercise  Price under Section  11(b) hereof,  the
following will be applicable:

                        (A) Issuance of Rights or Options. If the Company in any
manner  issues  or  grants  any  warrants,  rights or  options,  whether  or not
immediately  exercisable,  to subscribe for or to purchase Common Stock or other
securities  exercisable,  convertible  into or  exchangeable  for  Common  Stock
("Convertible Securities") (such warrants, rights and options to purchase Common
Stock or Convertible  Securities are  hereinafter  referred to as "Options") and
the  effective  price  per share for which  Common  Stock is  issuable  upon the
exercise of such  Options is less than the  Exercise  Price  ("Below  Base Price
Options"), then the maximum total number of shares of Common Stock issuable upon
the  exercise  of all such Below Base Price  Options  (assuming  full  exercise,
conversion or exchange of Convertible Securities, if applicable) will, as of the
date of the issuance or grant of such Below Base Price Options,  be deemed to be

<PAGE>
                                      -8-

outstanding  and to have been  issued and sold by the Company for such price per
share and the maximum  consideration  payable to the Company upon such  exercise
(assuming full exercise,  conversion or exchange of Convertible  Securities,  if
applicable) will be deemed to have been received by the Company. For purposes of
the preceding sentence, the "effective price per share for which Common Stock is
issuable  upon the exercise of such Below Base Price  Options" is  determined by
dividing (i) the total amount,  if any, received or receivable by the Company as
consideration for the issuance or granting of all such Below Base Price Options,
plus the minimum aggregate amount of additional  consideration,  if any, payable
to the Company upon the exercise of all such Below Base Price Options,  plus, in
the case of Convertible  Securities  issuable upon the exercise or conversion of
such  Below Base Price  Options,  the  minimum  aggregate  amount of  additional
consideration  payable upon the exercise,  conversion or exchange thereof at the
time such  Convertible  Securities  first  become  exercisable,  convertible  or
exchangeable,  by (ii) the  maximum  total  number of  shares  of  Common  Stock
issuable upon the exercise of all such Below Base Price Options  (assuming  full
conversion of Convertible Securities,  if applicable).  No further adjustment to
the  Exercise  Price will be made upon the actual  issuance of such Common Stock
upon the  exercise  of such  Below  Base  Price  Options  or upon the  exercise,
conversion or exchange of Convertible  Securities issuable upon exercise of such
Below Base Price Options.

                        (B) Issuance of Convertible  Securities.  If the Company
in any  manner  issues  or sells  any  Convertible  Securities,  whether  or not
immediately  convertible  (other  than  where  the  same are  issuable  upon the
exercise of Options) and the effective price per share for which Common Stock is
issuable  upon such  exercise,  conversion or exchange is less than the Exercise
Price, then the maximum total number of shares of Common Stock issuable upon the
exercise,  conversion or exchange of all such Convertible Securities will, as of
the  date of the  issuance  of such  Convertible  Securities,  be  deemed  to be
outstanding  and to have been  issued and sold by the Company for such price per
share and the maximum  consideration  payable to the Company upon such  exercise
(assuming full exercise,  conversion or exchange of Convertible  Securities,  if
applicable)  will be  deemed  to have  been  received  by the  Company.  For the
purposes of the preceding  sentence,  the  "effective  price per share for which
Common  Stock is  issuable  upon  such  exercise,  conversion  or  exchange"  is
determined by dividing (i) the total amount,  if any,  received or receivable by
the Company as  consideration  for the issuance or sale of all such  Convertible
Securities,  plus the minimum aggregate amount of additional  consideration,  if
any, payable to the Company upon the exercise, conversion or exchange thereof at
the time such Convertible  Securities first become  exercisable,  convertible or
exchangeable,  by (ii) the  maximum  total  number of  shares  of  Common  Stock
issuable  upon the  exercise,  conversion  or exchange  of all such  Convertible
Securities.  No further  adjustment to the Exercise  Price will be made upon the
actual  issuance of such Common Stock upon  exercise,  conversion or exchange of
such Convertible Securities.

                        (C) Change in Option Price or Conversion  Rate. If there
is a change at any time in (i) the amount of additional consideration payable to
the Company  upon the  exercise of any  Options;  (ii) the amount of  additional
consideration,  if any, payable to the Company upon the exercise,  conversion or
exchange  of any  Convertible  Securities;  or  (iii)  the  rate  at  which  any
Convertible Securities are convertible into or exchangeable for Common Stock (in
each such case, other than under or by reason of provisions  designed to protect
against

<PAGE>
                                      -9-

dilution),  the  Exercise  Price in  effect at the time of such  change  will be
readjusted  to the  Exercise  Price which would have been in effect at such time
had such Options or Convertible  Securities still outstanding  provided for such
changed additional consideration or changed conversion rate, as the case may be,
at the time initially granted, issued or sold.

                        (D) Calculation of Consideration Received. If any Common
Stock, Options or Convertible  Securities are issued,  granted or sold for cash,
the  consideration  received  therefor  for purposes of this Warrant will be the
amount  received  by  the  Company  therefor,  before  deduction  of  reasonable
commissions,  underwriting  allowances  or  other  reasonable  expenses  paid or
incurred by the Company in connection with such issuance, grant or sale. In case
any Common Stock,  Options or  Convertible  Securities  are issued or sold for a
consideration  part or all of which shall be other than cash,  the amount of the
consideration  other than cash  received by the Company  will be the fair market
value  of such  consideration,  except  where  such  consideration  consists  of
securities,  in which case the amount of  consideration  received by the Company
will be the fair  market  value  (closing  bid price,  if traded on any  market)
thereof  as of the  date of  receipt.  In case  any  Common  Stock,  Options  or
Convertible Securities are issued in connection with any merger or consolidation
in which the Company is the surviving  corporation,  the amount of consideration
therefor  will be deemed to be the fair market  value of such portion of the net
assets and business of the non-surviving  corporation as is attributable to such
Common Stock,  Options or Convertible  Securities,  as the case may be. The fair
market  value  of any  consideration  other  than  cash  or  securities  will be
determined in good faith by an investment banker or other appropriate  expert of
national  reputation  selected by the Company and  reasonably  acceptable to the
holder hereof, with the costs of such appraisal to be borne by the Company.

                        (E)   Exceptions  to   Adjustment  of  Exercise   Price.
Notwithstanding  anything to the contrary  herein,  this Section 11(b) shall not
apply to the  following  (1) the  granting  of options to  employees,  officers,
directors  or  consultants  of the Company  pursuant to any stock option plan or
other  written  compensatory  agreement  duly  adopted  by  a  majority  of  the
non-employee  members of the Board of  Directors of the Company or a majority of
the  members of a  committee  of  non-employee  directors  established  for such
purpose, or (2) the exercise of any security issued by the Company in connection
with the offer and sale of the  Company's  securities  pursuant to the  Purchase
Agreement  (including  any  securities  issued  as  compensation  in  connection
therewith),  or (3) the exercise of or conversion of any convertible securities,
options or warrants  issued and  outstanding  on the date hereof,  provided such
securities  have not been amended since the date hereof,  or (4) the issuance of
securities in connection with acquisitions, joint ventures, arrangements related
to the Company's  operations  and strategic  relationships,  or other  strategic
investments, the primary purpose of which is not to raise capital.

                  (iii) Minimum  Adjustment of Exercise  Price. No adjustment of
the  Exercise  Price shall be made in an amount of less than 1% of the  Exercise
Price in effect at the time such  adjustment  is otherwise  required to be made,
but any such lesser adjustment shall be carried forward and shall be made at the
time and together with the next subsequent  adjustment which,  together with any
adjustments  so  carried  forward,  shall  amount  to not  less  than 1% of such
Exercise Price.
<PAGE>
                                      -10-

      12. Reorganization, Reclassification, Merger, Consolidation or Disposition
of Assets.  In case the Company shall  reorganize  its capital,  reclassify  its
capital stock (other than as set forth in Section 11), consolidate or merge with
or into another corporation (where the Company is not the surviving  corporation
or where  there is a change  in or  distribution  with  respect  to any class of
common stock of the Company),  or sell,  transfer or otherwise dispose of all or
substantially all its property,  assets or business to another  corporation and,
pursuant  to  the  terms  of  such  reorganization,   reclassification,  merger,
consolidation or disposition of assets,  shares of common stock of the successor
or acquiring  corporation,  or any cash,  shares of stock or other securities or
property of any nature whatsoever  (including  warrants or other subscription or
purchase  rights) in addition to or in lieu of common stock of the  successor or
acquiring  corporation ("Other Property"),  are to be received by or distributed
to the holders of Common  Stock of the  Company,  then the Holder shall have the
right thereafter to receive, upon exercise of this Warrant, the number of shares
of Common Stock of the successor or acquiring  corporation or of the Company, if
it is the surviving  corporation,  and Other  Property  receivable  upon or as a
result  of  such  reorganization,  reclassification,  merger,  consolidation  or
disposition  of assets by a Holder of the  number of shares of Common  Stock for
which this Warrant is exercisable  immediately  prior to such event.  In case of
any such reorganization,  reclassification, merger, consolidation or disposition
of assets,  the successor or acquiring  corporation  (if other than the Company)
shall expressly  assume the due and punctual  observance and performance of each
and every covenant and condition of this Warrant to be performed and observed by
the Company and all the obligations and liabilities  hereunder,  subject to such
modifications  as may be deemed  appropriate  (as  determined  in good  faith by
resolution  of the Board of  Directors  of the  Company) in order to provide for
adjustments of Warrant Shares for which this Warrant is exercisable  which shall
be as nearly  equivalent as practicable to the adjustments  provided for in this
Section 12. For purposes of this Section 12,  "common  stock of the successor or
acquiring  corporation"  shall  include stock of such  corporation  of any class
which is not  preferred  as to dividends or assets over any other class of stock
of such  corporation  and which is not  subject  to  redemption  and shall  also
include any evidences of indebtedness, shares of stock or other securities which
are convertible into or exchangeable for any such stock,  either  immediately or
upon the arrival of a specified  date or the happening of a specified  event and
any warrants or other rights to  subscribe  for or purchase any such stock.  The
foregoing  provisions  of this Section 12 shall  similarly  apply to  successive
reorganizations,  reclassifications,  mergers,  consolidations or disposition of
assets.

      13.  Voluntary  Adjustment  by the  Company.  The  Company may at any time
during the term of this Warrant  reduce the then current  Exercise  Price to any
amount and for any period of time deemed  appropriate  by the Board of Directors
of the Company.

      14. Notice of Adjustment.  Whenever the number of Warrant Shares or number
or kind of securities or other  property  purchasable  upon the exercise of this
Warrant or the Exercise Price is adjusted, as herein provided, the Company shall
give  notice  thereof to the  Holder,  which  notice  shall  state the number of
Warrant Shares (and other securities or property)  purchasable upon the exercise
of this  Warrant  and the  Exercise  Price of such  Warrant  Shares  (and  other
securities or property) after such  adjustment,  setting forth a brief statement
of the facts  requiring  such  adjustment  and setting forth the  computation by
which such adjustment was made.

<PAGE>
                                      -11-

      15. Notice of Corporate Action. If at any time:

            (a) the  Company  shall  take a record of the  holders of its Common
Stock  for the  purpose  of  entitling  them to  receive  a  dividend  or  other
distribution,  or any right to subscribe  for or purchase  any  evidences of its
indebtedness,  any  shares  of stock of any  class or any  other  securities  or
property, or to receive any other right, or

            (b) there shall be any capital  reorganization  of the Company,  any
reclassification  or recapitalization of the capital stock of the Company or any
consolidation  or merger of the  Company  with,  or any sale,  transfer or other
disposition of all or substantially all the property,  assets or business of the
Company to, another corporation or,

            (c)  there  shall  be  a  voluntary  or   involuntary   dissolution,
liquidation or winding up of the Company;

then, in any one or more of such cases, the Company shall give to Holder (i) at
least 10 days' prior written notice of the date on which a record date shall be
selected for such dividend, distribution or right or for determining rights to
vote in respect of any such reorganization, reclassification, merger,
consolidation, sale, transfer, disposition, liquidation or winding up, and (ii)
in the case of any such reorganization, reclassification, merger, consolidation,
sale, transfer, disposition, dissolution, liquidation or winding up, at least 10
days' prior written notice of the date when the same shall take place. Such
notice in accordance with the foregoing clause also shall specify (i) the date
on which any such record is to be taken for the purpose of such dividend,
distribution or right, the date on which the holders of Common Stock shall be
entitled to any such dividend, distribution or right, and the amount and
character thereof, and (ii) the date on which any such reorganization,
reclassification, merger, consolidation, sale, transfer, disposition,
dissolution, liquidation or winding up is to take place and the time, if any
such time is to be fixed, as of which the holders of Common Stock shall be
entitled to exchange their Warrant Shares for securities or other property
deliverable upon such disposition, dissolution, liquidation or winding up. Each
such written notice shall be sufficiently given if addressed to Holder at the
last address of Holder appearing on the books of the Company and delivered in
accordance with Section 17(d).

      16.  Authorized  Shares.  The Company covenants that during the period the
Warrant is outstanding,  it will reserve from its authorized and unissued Common
Stock a  sufficient  number of shares to provide for the issuance of the Warrant
Shares upon the exercise of any purchase rights under this Warrant.  The Company
further  covenants  that its  issuance of this  Warrant  shall  constitute  full
authority  to its  officers  who are charged  with the duty of  executing  stock
certificates  to execute and issue the  necessary  certificates  for the Warrant
Shares upon the exercise of the purchase rights under this Warrant.  The Company
will take all such  reasonable  action as may be  necessary  to assure that such
Warrant  Shares  may be issued  as  provided  herein  without  violation  of any
applicable law or regulation,  or of any  requirements of the principal  Trading
Market upon which the Common Stock may be listed.

            (a)  Except  and to the  extent  as waived  or  consented  to by the
Holder,  the Company  shall not by any action,  including,  without  limitation,
amending  its  certificate  of

<PAGE>
                                      -12-

incorporation or through any reorganization,  transfer of assets, consolidation,
merger, dissolution,  issue or sale of securities or any other voluntary action,
avoid or seek to avoid the observance or performance of any of the terms of this
Warrant,  but will at all times in good faith  assist in the carrying out of all
such  terms  and in the  taking  of all  such  actions  as may be  necessary  or
appropriate to protect the rights of Holder as set forth in this Warrant against
impairment.  Without limiting the generality of the foregoing,  the Company will
(a) not  increase the par value of any Warrant  Shares above the amount  payable
therefor upon such exercise immediately prior to such increase in par value, (b)
take all such  action  as may be  necessary  or  appropriate  in order  that the
Company  may validly and  legally  issue  fully paid and  nonassessable  Warrant
Shares upon the exercise of this Warrant,  and (c) use  commercially  reasonable
efforts to obtain  all such  authorizations,  exemptions  or  consents  from any
public regulatory body having jurisdiction thereof as may be necessary to enable
the Company to perform its obligations under this Warrant.

            (b) Before  taking any action which would result in an adjustment in
the number of Warrant  Shares for which this  Warrant is  exercisable  or in the
Exercise Price, the Company shall obtain all such  authorizations  or exemptions
thereof,  or consents  thereto,  as may be necessary from any public  regulatory
body or bodies having jurisdiction thereof.

      17. Miscellaneous.

            (a) Jurisdiction.  This Agreement shall be governed by and construed
in accordance  with the internal laws of the State of New York without regard to
the conflicts of laws principles thereof.  The parties hereto hereby irrevocably
agree that any suit or proceeding arising directly and/or indirectly pursuant to
or under this  Agreement,  shall be brought  solely in a federal or state  court
located in the City, County and State of New York. By its execution hereof,  the
parties hereby covenant and irrevocably  submit to the in personam  jurisdiction
of the federal  and state  courts  located in the City,  County and State of New
York and agree  that any  process in any such  action may be served  upon any of
them  personally,  or by certified  mail or  registered  mail upon them or their
agent,  return  receipt  requested,  with the same full  force and  effect as if
personally served upon them in New York City. The parties hereto waive any claim
that  any such  jurisdiction  is not a  convenient  forum  for any such  suit or
proceeding  and any defense or lack of in  personam  jurisdiction  with  respect
thereto.  In the event of any such action or  proceeding,  the party  prevailing
therein  shall be  entitled  to  payment  from the  other  party  hereto  of its
reasonable counsel fees and disbursements in an amount judicially determined.

            (b)  Restrictions.  The Holder  acknowledges that the Warrant Shares
acquired upon the exercise of this Warrant,  if not  registered for resale under
the  Securities  Act, will have legends  imprinted  upon any stock  certificates
evidencing such Warrant Shares and the Company will notify its transfer agent of
restrictions upon resale imposed by the applicable state and federal  securities
laws.

            (c)  Nonwaiver  and  Expenses.  No course of dealing or any delay or
failure to exercise any right hereunder on the part of Holder shall operate as a
waiver of such right or otherwise prejudice Holder's rights, powers or remedies,
notwithstanding  all rights hereunder  terminate on the Termination Date. If the
Company  willfully  and  knowingly  fails to comply with

<PAGE>
                                      -13-

any  provision of this  Warrant,  which  results in any material  damages to the
Holder,  the Company  shall pay to Holder such amounts as shall be sufficient to
cover  any  costs  and  expenses  including,  but  not  limited  to,  reasonable
attorneys' fees, including those of appellate proceedings, incurred by Holder in
collecting any amounts due pursuant hereto or in otherwise  enforcing any of its
rights, powers or remedies hereunder.

            (d)  Notices.  Any  notice,  request or other  document  required or
permitted  to be  given or  delivered  to the  Holder  by the  Company  shall be
delivered in accordance  with the notice  provisions of the Purchase  Agreement;
provided,  upon any permitted  assignment of this  Warrant,  the assignee  shall
promptly provide the Company with its contact information.

            (e) Limitation of Liability.  No provision hereof, in the absence of
any  affirmative  action by Holder to exercise this Warrant or purchase  Warrant
Shares, and no enumeration  herein of the rights or privileges of Holder,  shall
give rise to any liability of Holder for the purchase  price of any Common Stock
or as a stockholder  of the Company,  whether such  liability is asserted by the
Company or by creditors of the Company.

            (f) Remedies.  Holder, in addition to being entitled to exercise all
rights  granted by law,  including  recovery  of  damages,  will be  entitled to
specific  performance of its rights under this Warrant.  The Company agrees that
monetary  damages  would not be adequate  compensation  for any loss incurred by
reason of a breach by it of the  provisions of this Warrant and hereby agrees to
waive the defense in any action for  specific  performance  that a remedy at law
would be adequate.

            (g) Successors and Assigns.  Subject to applicable  securities laws,
this Warrant and the rights and obligations  evidenced hereby shall inure to the
benefit of and be binding upon the  successors of the Company and the successors
and permitted assigns of Holder.  The provisions of this Warrant are intended to
be for the benefit of all Holders from time to time of this Warrant and shall be
enforceable by any such Holder or holder of Warrant Shares.

            (h)  Amendment.  This  Warrant  may be  modified  or  amended or the
provisions hereof waived with the written consent of the Company and the Holder.

            (i) Severability.  Wherever possible, each provision of this Warrant
shall  be  interpreted  in  such  manner  as to be  effective  and  valid  under
applicable  law, but if any  provision of this Warrant shall be prohibited by or
invalid under  applicable law, such provision shall be ineffective to the extent
of such  prohibition or invalidity,  without  invalidating the remainder of such
provisions or the remaining provisions of this Warrant.

            (j)  Headings.  The  headings  used  in  this  Warrant  are  for the
convenience of reference  only and shall not, for any purpose,  be deemed a part
of this Warrant.

                  [Remainder of page intentionally left blank]

<PAGE>
                                      -14-

      IN WITNESS WHEREOF,  the Company has caused this Warrant to be executed by
its officer thereunto duly authorized.

Dated: April __, 2004

                                                  DYNTEK , INC.

                                                  By:
                                                     ___________________________
                                                        Name:
                                                        Title:

[________________________________]

By:
   ___________________________
      Name:
      Title:

<PAGE>

                               NOTICE OF EXERCISE

To: DynTek, Inc.

      1. The  undersigned  hereby elects to purchase  ________  Series A Warrant
Shares of DynTek,  Inc.  pursuant to the terms of the attached  Series A Warrant
(only if exercised in full),  and tenders herewith payment of the exercise price
in full, together with all applicable transfer taxes, if any.

      2. Payment shall take the form of (check applicable box):

            |_|   in lawful money of the United States; or

            |_|   the  cancellation of such number of Series A Warrant Shares as
                  is  necessary,  in  accordance  with the  formula set forth in
                  subsection  3(d),  to  exercise  this  Series A  Warrant  with
                  respect  to the  maximum  number of  Series A  Warrant  Shares
                  purchasable  pursuant to the cashless  exercise  procedure set
                  forth in subsection 3(d).

      3. Please issue a certificate or certificates  representing  said Series A
Warrant  Shares  in the  name of the  undersigned  or in such  other  name as is
specified below:

                         ------------------------------

        The Series A Warrant Shares shall be delivered to the following:

                         ------------------------------

      4. Accredited  Investor.  The  undersigned is an "accredited  investor" as
defined  in  Regulation  D  promulgated  under the  Securities  Act of 1933,  as
amended.

                                                   [PURCHASER]

                                                   By:
                                                      --------------------------
                                                         Name:
                                                         Title:
<PAGE>

                                 ASSIGNMENT FORM

(To assign the foregoing warrant, execute this form and supply required
information. Do not use this form to exercise the warrant.)

      FOR  VALUE  RECEIVED,  the  foregoing  Series  A  Warrant  and all  rights
evidenced thereby are hereby assigned to

      _______________________________________, whose address is:

      __________________________________________________________

      __________________________________________________________

Dated:____________________, 200_

                                  Holder's Signature:___________________________

                                  Holder's Address:_____________________________

                                  ______________________________________________

Signature Guaranteed:___________________________

NOTE: The signature to this Assignment Form must correspond with the name as it
appears on the face of the Series A Warrant, without alteration or enlargement
or any change whatsoever, and must be guaranteed by a bank or trust company.
Officers of corporations and those acting in a fiduciary or other representative
capacity should file proper evidence of authority to assign the foregoing Series
A Warrant.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00065-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00065-of-00352.parquet"}]]